{"id":"W4393252428","doi":"10.1200/jco.23.02329","title":"Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada); Spinal Cord Injury BC; University of British Columbia; McGill University; Jewish General Hospital","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Refractory (planetary science); Clinical endpoint; Internal medicine; Phases of clinical research; Clinical trial; Lymphoma; Non-Hodgkin's lymphoma; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01304975,0.0004699375,0.001579773,0.0005720627,0.0003955167,0.001436672,0.0004534895,0.0006247929,0.001200988],"category_scores_gemma":[0.004700364,0.0002293435,0.002003821,0.0006617155,0.0004504847,0.001131972,0.0004819992,0.001715191,0.0003060379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007580352,"about_ca_system_score_gemma":0.0005990275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003637962,"about_ca_topic_score_gemma":0.0008520985,"domain_scores_codex":[0.9973632,0.001269882,0.0002813185,0.0003404879,0.0004264468,0.0003186634],"domain_scores_gemma":[0.9923252,0.002352869,0.002539705,0.001247514,0.0006054286,0.0009293878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2017289,0.005376478,0.3460908,0.001937674,0.01336483,0.0007912006,0.0008440052,0.003462166,0.03585379,0.0003715038,0.00347778,0.3867008],"study_design_scores_gemma":[0.01480679,0.1438915,0.8039322,0.0004736819,0.0101628,0.001560498,0.0002832838,0.00314222,0.008787976,0.0005548083,0.01231774,0.00008660051],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843467,0.01142476,0.00119766,0.0001813788,0.00005601079,0.0003324011,0.0009280895,0.00004682636,0.001486174],"genre_scores_gemma":[0.9957819,0.001288262,0.0004720644,0.0002599331,0.00008839654,0.000145505,0.001473693,0.00001251902,0.0004778298],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01304975,"threshold_uncertainty_score":0.06901449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08335546380125415,"score_gpt":0.4715924011792489,"score_spread":0.3882369373779948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}